LR
Therapeutic Areas
Enthera Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ent001 | Type 1 Diabetes & Inflammatory Bowel Disease (Ulcerative Colitis) | Phase 1 |
| Ebrasodebart | Autoimmune Disorders (specifics not fully detailed) | Preclinical or Early Clinical |